Skip to main content
Immunovia logo

Immunovia — Investor Relations & Filings

Ticker · IMMNOV ISIN · SE0006091997 LEI · 549300KHWL6KK1XGUO81 ST Human health and social work activities
Open in API
Filings indexed 374 across all filing types
Latest filing 2025-10-03 Share Issue/Capital Cha…
Country SE Sweden
Listing ST IMMNOV

About Immunovia

https://immunovia.com/

Immunovia is a diagnostics company focused on revolutionizing the early detection of pancreatic cancer. Its primary product is the PancreaSure test, a simple blood test designed to detect pancreatic cancer at Stage 1 and 2 with high accuracy. The test is intended for annual surveillance of individuals at elevated risk due to family history or genetic mutations. PancreaSure functions by detecting proteins and other biomarkers indicative of pancreatic cancer growth. The company's mission is to improve survival rates for this highly lethal cancer by enabling diagnosis at its earliest, most treatable stages, offering a convenient alternative to invasive imaging procedures.

Recent filings

Filing Released Lang Actions
Immunovia offentliggör informationsdokument avseende företrädesemission
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing the publication of an 'Informationsdokument' (Information Document) related to a rights issue (företrädesemission). It explicitly states that the document is not a prospectus and provides links to where the information document can be found on the company's website. Following the 'Menu vs Meal' rule, this is an announcement of a report/document rather than the report itself, making it a Report Publication Announcement.
2025-10-03 Swedish
Kommuniké från extra bolagsstämma i Immunovia AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a 'Kommuniké från extra bolagsstämma' (Communiqué from an Extraordinary General Meeting) for Immunovia AB. It details the specific decisions made during the meeting, including amendments to the articles of association and approval of a rights issue (företrädesemission). Since this document reports the official outcomes and resolutions of a shareholder meeting, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-09-29 Swedish
Bulletin from the extraordinary general meeting in Immunovia AB (publ)
AGM Information Classification · 1% confidence The document is a bulletin from an Extraordinary General Meeting (EGM) detailing the resolutions passed by shareholders, specifically regarding amendments to the Articles of Association and the approval of a rights issue. While it mentions voting outcomes, it is primarily a summary of the meeting's decisions and corporate actions taken. Since it covers the results of the meeting's resolutions, it falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-09-29 English
Immunovia announces final terms of rights issue
Capital/Financing Update Classification · 1% confidence The document is a press release from Immunovia AB announcing the final terms of a rights issue (a capital raise). It details the subscription price, the number of shares to be issued, the subscription period, and the use of proceeds. This falls under the category of capital and financing updates, specifically regarding share issuance and capital structure changes. It is not a prospectus itself, but an announcement of the terms of the rights issue.
2025-09-25 English
Immunovia offentliggör slutliga villkor i företrädesemission
Share Issue/Capital Change Classification · 1% confidence The document is a press release from Immunovia AB announcing the final terms of a rights issue (företrädesemission). It details the subscription price, subscription ratio, subscription period, and the involvement of underwriters. This falls under the category of capital structure changes and financing activities. According to the filing definitions, announcements regarding new share issues or capital changes are classified as 'SHA'.
2025-09-25 Swedish
Immunovia enters into top guarantee commitments for the upcoming rights issue
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing 'top guarantee commitments' for an upcoming rights issue of shares by Immunovia AB. It details the financial structure of the rights issue, the role of guarantors, and the timeline for the upcoming Extraordinary General Meeting. Since this document describes a capital-raising activity (rights issue) and the securing of guarantee commitments, it falls under the category of Capital/Financing Update.
2025-09-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.